Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HDM2017 Combination Therapy in Advanced Colorectal Cancer
NCT07805551Phase 2Recruiting
- Sponsor
- Huadong Medicine
- Start
- Aug 2026
- Primary completion
- Aug 2030
- Countries
- 1
01
Overview
A Phase 2 trial of HDM2017 in colorectal cancer (CRC), sponsored by Huadong Medicine. Started Aug 2026; status: recruiting.
02
Drugs
HDM2017
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07805551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07805551.